"10.1371_journal.pone.0141806","plos one","2015-11-23T00:00:00Z","Mark E Larsen; Lisa Curry; Nikolaos Mastellos; Catherine Robb; Josip Car; Lefkos T Middleton","Global eHealth Unit, School of Public Health, Imperial College London, London, United Kingdom; Neuroepidemiology and Ageing Research Unit, School of Public Health, Imperial College London, London, United Kingdom; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore","Conceived and designed the experiments: JC LTM. Performed the experiments: MEL LC NM CR. Analyzed the data: MEL. Wrote the paper: MEL LC NM JC LTM.","The CHARIOT register was made possible with funding from Janssen Pharmaceuticals, AstraZeneca, Zinfandel Pharmaceuticals and Takeda. None of the authors hold any agreements with the funders in relation to patents, products in development relevant to this study or marketed products. L. Middleton has a consultancy agreement with AstraZeneca with respect to the Amaranth Clinical study and previously held a consultancy agreement with Janssen Pharmaceuticals. He is the UK Investigator of the Takeda TOMMORROW trial and the AstraZeneca Amaranth trial. This does not alter our adherence to PLOS ONE policies on sharing data and materials.","2015","11","Mark E Larsen","MEL",6,TRUE,2,4,1,5,TRUE,TRUE,FALSE,0,NA,FALSE
